Ara mostrant els elements 1-7 de 7
Braga Pereira, Joana (Data de defensa: 2012-07-20)
Parkinson’s disease (PD) is currently the second most common neurodegenerative disorder after Alzheimer’s disease (AD), affecting 100.000 people in Spain and more than 4 million people worldwide. Being ...
Inguanzo Pons, Anna (Data de defensa: 2021-10-01)
[eng] INTRODUCTION: Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB) appear as neurodegenerative disorders with a wide range of symptomatology that differs among patients, among which are ...
Ibarretxe Bilbao, Naroa (Data de defensa: 2009-12-21)
According neuropathological research limbic changes occur in Parkinson's disease with and without dementia. Structural MRI have reported atrophy of limbic structures including amygadala and hippocampus, ...
Sala Llonch, Roser (Data de defensa: 2015-01-13)
Aquesta tesi inclou 6 estudis en els quals s’han utilitzat diversos mètodes d’imatge per ressonància magnètica (IRM) per caracteritzar la connectivitat cerebral i la seva relació amb l’estat cognitiu ...
Uribe Codesal, Carme (Data de defensa: 2019-05-03)
BACKGROUND AND OBJECTIVES. Parkinson’s disease is a heterogenous neurodegenerative disorder. To characterize homogeneous groups of PD patients, PD phenotypes have been described based on clinical data ...
Ortiz Gil, Jordi (Data de defensa: 2012-09-14)
Background: In recent years it has become recognized that schizophrenia is associated with cognitive impairment, which affects particularly executive function and memory. Although cognitive impairment ...
Oltra González, Javier (Data de defensa: 2022-10-28)
[eng] INTRODUCTION: This doctoral thesis is centered on Parkinson’s disease (PD) with rapid eye movement sleep behavior disorder (RBD) as a clinical subtype. Characterizing subtypes is one of the ...